Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Electrolyte balance in the gastrointestinal tract refers broadly to the dynamic processes by which water and various ions (notably sodium, potassium, chloride) are absorbed from or secreted into the intestinal lumen. This ensures proper hydration status for both local digestive function and systemic homeostasis. The small intestine absorbs most ingested fluids along with nutrients; any excess fluid is reclaimed efficiently by the colon. Disruption can result in diarrhea (excessive loss), constipation (excessive retention), dehydration, or systemic electrolyte imbalances. While many drugs can influence these processes indirectly via effects on ion channels/transporters within enterocytes—for example diuretics acting elsewhere may alter GI losses—the term itself does not denote any one actionable therapeutic target but rather an essential aspect of normal physiology maintained through coordinated action across multiple cell types and organs[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Electrolyte balance in gastrointestinal tract.